Evidence map›Paper›PMID 18025046›Full record

ArticleNucleic acids research2008

Nucleolin regulates c-Jun/Sp1-dependent transcriptional activation of cPLA2alpha in phorbol ester-treated non-small cell lung cancer A549 cells.

Jen-Hui Tsou, Kwang-Yu Chang, Wei-Chiao Wang, Joseph T Tseng, Wu-Chou Su, Liang-Yi Hung, Wen-Chang Chang, Ben-Kuen Chen

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Association between leptin gene G-2548A polymorphism with metabolic syndrome.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2013
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Jen-Hui TsouDepartment of Pharmacology, National Cheng Kung University, Tainan 701, Taiwan.
Kwang-Yu Chang
Wei-Chiao Wang
Joseph T Tseng
Wu-Chou Su
Liang-Yi Hung
Wen-Chang Chang
Ben-Kuen Chen
National Cheng Kung University · TWGene Signal (Switzerland) · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The expression of cPLA2 is critical for transformed growth of non-small cell lung cancer (NSCLC). It is known that phorbol 12-myristate 13-acetate (PMA)-activated signal transduction pathway is thought to be involved in the oncogene action in NSCLC and enzymatic activation of cPLA2. However, the transcriptional regulation of cPLA2alpha in PMA-activated NSCLC is not clear. In this study, we found that PMA induced the mRNA level and protein expression of cPLA2alpha. In addition, two Sp1-binding sites of cPLA2alpha promoter were required for response to PMA and c-Jun overexpression. Small interfering RNA (siRNA) of c-Jun and nucleolin inhibited PMA induced the promoter activity and protein expression of cPLA2alpha. Furthermore, PMA stimulated the formation of c-Jun/Sp1 and c-Jun/nucleolin complexes as well as the binding of these transcription factor complexes to the cPLA2alpha promoter. Although Sp1-binding sites were required for the bindings of Sp1 and nucleolin to the promoter, the binding of nucleolin or Sp1 to the promoter was independent of each other. Our results revealed that c-Jun/nucleolin and c-Jun/Sp1 complexes play an important role in PMA-regulated cPLA2alpha gene expression. It is likely that nucleolin binding at place of Sp1 on gene promoter could also mediate the regulation of c-Jun/Sp1-activated genes.

Indexed as

Gene Expression Regulation, NeoplasticTranscriptional ActivationCarcinoma, Non-Small-Cell LungCell Line, TumorGC Rich SequenceGroup IV Phospholipases A2HumansLung NeoplasmsNucleolinPhosphoproteinsPromoter Regions, GeneticProto-Oncogene Proteins c-junRNA-Binding ProteinsSp1 Transcription FactorTetradecanoylphorbol AcetateTranscription FactorsGroup IV Phospholipases A2NucleolinPhosphoproteinsProto-Oncogene Proteins c-junRNA-Binding ProteinsSp1 Transcription FactorTetradecanoylphorbol AcetateTranscription Factors

Identifiers

PMID18025046
PMCPMC2248756
OpenAlexW2124420821

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.